Carlson Rezidor Western Europe Joins the Solution

Carlson Rezidor Western Europe Joins the Solution

by | Dec 21, 2017 | News, Venues

We are pleased to announce that Carlson Rezidor Hotel group have initiated a programme to assess and train 15 hotels within the western Europe region as part of their strategy for healthcare sector meeting and events. This follows the successful programmes in London, Stansted Airport, Liverpool, Manchester Airport, Berlin, and Amsterdam.

To learn more, contact our team here or contact the Carlson Rezidor healthcare specialist team here

Radisson Blu Astrid Hotel, Antwerp

Radisson Blu, Ajaccio

Radisson Blu, Biarritz

Radisson Blu Hotel, Paris-Boulogne

Radisson Blu Hotel Royal, Brussels

Park Inn Brussels Midi

Park Inn Brussels Airport

Park Inn Lille

Park Inn, Leuven

Radisson Blu Lyon

Radisson Blu Hotel, Marseille

Park Inn Nice

Radisson Blu Hotel Nice

Radisson Blu Hotel at Disneyland Resort, Paris

Radisson Blu Hotel, Toulouse Airport

To learn more, contact our team here or contact the Carlson Rezidor healthcare specialist team here

“Pharma” comes out Fighting – The Blame Game

“Pharma” comes out Fighting – The Blame Game

by | Dec 13, 2017 | Experts, Thought Leadership

The Healthcare, Life Science and Medical Device industries are often challenged on the compatibility of their role in patient care, with a commercial interest. Simply, many people don’t like the idea of someone “getting rich” on health outcomes. Indeed, there are many organisations that are seen to be “blamed” for deficiencies in healthcare systems. An assumption cycle many want to change.

“Industry charges too much for its innovative new treatments”

“HTA bodies don’t consider life time and societal value”

“Payers focus on cost containment not outcomes”

“Governments don’t make adequate provision for healthcare”

We have seen the creation of Transparency programmes in the US and Europe to reveal the extent of financial relationships, including meeting costs, between industry and Healthcare Professionals. A tangible attempt to change this perception of an industry which has developed almost 90% of the worlds medicines without, in the majority, tax funding.

This short blog from EFPIA, an organisation that represents the Pharmaceutical industry in Europe, shows how the industry is determined to demonstrate its value to patient care and challenge some of the assumptions in the healthcare system.

A relentless commitment to the blame game See the US Open Payments, US and ABPI, UK platforms to view transparency in action. Type in your Doctors name, see what pops up!

Changes to French Hospitality Limits Expected

Changes to French Hospitality Limits Expected

by | Nov 2, 2017 | Experts, News

It is expected that CNOM Conseil National de l’Ordre des Médecins (Physicians Council) who manage the approval process for French HCPs to attend meetings, will change significantly the amount of time physicians can work for healthcare companies and raise the limits applied to meal and accommodation expenses for meetings attended by Physicians. We understand that this is not yet approved by LEEM the French industry association and that their code of practice relating to honoraria payments and hospitality limits remains the same.

  • Travel time to meeting could be paid
  • HCPs allowed a maximum of 20 working days per year with healthcare companies
  • Hourly rate increased to €250
  • Meals limits increased from €60 to €70 including taxes
  • Accommodation limits of; €325 in Europe (capital cities), €350 in Asia, Switzerland, the USA and Australia.
  • We will monitor the response of the Healthcare and Life science companies to assess if these changes will be adopted in their codes of practice and company policies.

Feel free to contact [email protected] for further information.

 

What could Brexit Mean to Healthcare Meetings & Events?

What could Brexit Mean to Healthcare Meetings & Events?

by | Oct 16, 2017 | News

We are not Brexit specialists but recognise that Brexit might have the potential to effect the landscape for meetings across the UK and mainland Europe. Take a look at our linkedin post here Highlight “Medicine Supply – currently without any agreement in sight drugs manufactured in the UK will not have regulatory approval for use in Europe.”
3Sixty Event Consulting_Resources_News_What could Brexit Mean to Healthcare Meetings and Events
New data released by ABPI

New data released by ABPI

by | Oct 7, 2017 | Compliance, News

Whilst it is not currently mandatory for a HCP to consent for the use of data for the reporting of Transfers of Value (TOV), it is clear from the ‘significant increase’ in numbers from 2015 that HCPs are more confident in showing complete transparency of their interactions with the pharmaceutical industry.

With this increase in numbers, certainly for the UK and likely repeated across Europe, it underlines the requirement for venues to proactively provide unbundled rates and speed up the process of meeting enquiry and booking.

To read the full ABPI report, Click Here